Maze Therapeutics, Inc. (MAZE) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US5787841007
Maze Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -142.90 m USD |
| EBIT | -131.12 m USD |
| Net income | -131.12 m USD |
| Diluted EPS – continuing operations | -3.05 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Maze Therapeutics, Inc.
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
More stocks
- Eco-Shop Marketing Berhad (5337.KL)
- Prosegur Compania de Seguridad SA (PSG.MC)
- Hyundai Elevator (017800.KS)
- Zooplus (ZO1.HM)
- Aktor Holding Company Technical And Energy Projects SA (INKAT.AT)
- Hydsoft Technology Co. Ltd. A (301316.SZ)
- Cofoe Medical Technology Co.Ltd. (301087.SZ)
- ALAMO GROUP INC (ALG)
- NCC AB (NCC B.ST)
- Nongshim (004370.KS)
- Shenzhen MeiG Smart Technology Co Ltd (002881.SZ)
- RHI Magnesita NV (RHIM.L)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.